Foghorn Leghorn was a great euphemistic cusser, though today some of his choices are problematic at best. But Yosemite Sam? He was the king, of course. His mouth was as trigger-happy as his hands. He ...

The seventy-six-year-old theatre diva, famed and feared for her salty bravado, dishes on Hal Prince, her non-friendship with ...

Foghorn Therapeutics Inc. has a one year low of $2.94 and a one year high of $10.25. The company’s fifty day moving average price is $3.94 and its 200 day moving average price is $4.98.

The filmmaker behind ‘The Last Jedi’ and the ‘Knives Out’ franchise speaks to Louis Chilton about the ‘war’ between fans, the ...

Foghorn’s partnership with Eli Lilly, along with the reiterated price target and rating by Citizens JMP, highlights the biotech firm’s strategic position in the oncology market.

CAMBRIDGE, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious ...

CAMBRIDGE, Mass. - Foghorn Therapeutics Inc. (NASDAQ:FHTX), a biotechnology firm focused on developing novel medicines through gene expression correction, announced today the appointment of two ...

CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Foghorn ® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious ...

The 94-year-old noted that he will not sell a single share of the company. We sell different types of products and services to both investment professionals and individual investors. These ...

CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Foghorn ® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by ...